UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 152

Sortiert nach

Extent of resection influences outcomes for patients with gliomas

Revue neurologique, 2011-10, Vol.167 (10), p.648-654

2011

Volltextzugriff (PDF)

Intracranial Aneurysms in Childhood: 27-Year Single-Institution Experience

American journal of neuroradiology : AJNR, 2009-08, Vol.30 (7), p.1315-1324

2009

Volltextzugriff (PDF)

Miniature in vivo MEMS-based line-scanned dual-axis confocal microscope for point-of-care pathology

Biomedical optics express, 2016-02, Vol.7 (2), p.251-263

2016

Volltextzugriff (PDF)

Emerging operative strategies in neurosurgical oncology

Current opinion in neurology, 2012-12, Vol.25 (6), p.756-766

2012

Volltextzugriff (PDF)

MECHANISMS OF DISEASE: Neural Stem Cells and the Origin of Gliomas

The New England journal of medicine, 2005-08, Vol.353 (8), p.811

2005

Volltextzugriff (PDF)

A Combined Phase 0/1b Trial of ATM Inhibitor AZD1390 in Combination with Radiation in Patients with Newly-Diagnosed, MGMT-Unmethylated Glioblastoma

International journal of radiation oncology, biology, physics, 2024-10, Vol.120 (2), p.e242-e243

2024

Volltextzugriff (PDF)

A Combined Phase 0/2 "Trigger" Trial Evaluating Pamiparib or Olaparib with Concurrent Radiotherapy in Patients with Newly-Diagnosed or Recurrent Glioblastoma

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e115-e115

2023

Volltextzugriff (PDF)

A Combined Phase 0/2 "Trigger" Trial of Niraparib in Combination with Radiation in Patients with Newly-Diagnosed Glioblastoma

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S86-S87

2023

Volltextzugriff (PDF)

505MO A phase 0/Ib study of AZD1390 plus radiotherapy in recurrent glioblastoma patients

Annals of oncology, 2023-10, Vol.34, p.S394-S394

2023

Volltextzugriff (PDF)

341O A phase 0 ‘Trigger’ trial of CDK4/6 plus ERK1/2 inhibitors in recurrent glioblastoma

Annals of oncology, 2021-09, Vol.32, p.S516-S516

2021

Volltextzugriff (PDF)

287MO A phase 0 ‘trigger’ trial of pamiparib in newly diagnosed and recurrent glioblastoma patients

Annals of oncology, 2022-09, Vol.33, p.S670

2022

Volltextzugriff (PDF)

Phase 0 trial of ceritinib in brain metastases and recurrent glioblastoma

Annals of oncology, 2019-10, Vol.30, p.v155

2019

Volltextzugriff (PDF)

427P - Phase 0 trial of ceritinib in brain metastases and recurrent glioblastoma

Annals of oncology, 2019-10, Vol.30, p.v155-v155

2019

Volltextzugriff (PDF)

A phase 0/II clinical trial of a CDK4/6 inhibitor in aggressive meningioma patients

Annals of oncology, 2019-10, Vol.30, p.v144

2019

Volltextzugriff (PDF)

392OA phase 0/II clinical trial of a CDK4/6 inhibitor in aggressive meningioma patients

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

427PPhase 0 trial of ceritinib in brain metastases and recurrent glioblastoma

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

392O - A phase 0/II clinical trial of a CDK4/6 inhibitor in aggressive meningioma patients

Annals of oncology, 2019-10, Vol.30, p.v144-v144

2019

Volltextzugriff (PDF)

OS05.8.A A Phase 0/1 ‘Trigger’ Trial of Ribociclib Plus Everolimus in Recurrent High-Grade Glioma

Neuro-oncology (Charlottesville, Va.), 2021-09, Vol.23 (Supplement_2), p.ii8-ii8

2021

Volltextzugriff (PDF)

347MO 5-Aminolevulinic acid sonodynamic therapy in recurrent glioblastoma: A first-in-human phase 0/1 clinical trial

Annals of oncology, 2021-09, Vol.32, p.S518-S519

2021

Volltextzugriff (PDF)

OS4.2 Phase 0 trial of Ceritinib in brain metastasis and recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (Supplement_3), p.iii10-iii10

2019

Volltextzugriff (PDF)

OS8.1 A phase 0/2 clinical trial of a CDK4/6 inhibitor in aggressive meningioma patients

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (Supplement_3), p.iii15-iii16

2019

Volltextzugriff (PDF)

Pediatric intracranial aneurysms: durability of treatment following microsurgical and endovascular management

Journal of neurosurgery, 2006-02, Vol.104 (2 Suppl), p.82-89

2006

Volltextzugriff (PDF)

P01.058 Higher immune associated markers (PD-L1, PD-1, TMB, MSI) in gliosarcoma compared to glioblastoma

Neuro-oncology (Charlottesville, Va.), 2018-09, Vol.20 (suppl_3), p.iii242-iii243

2018

Volltextzugriff (PDF)

GLIOMA STEM CELL HOMING TO THE HUMAN SUBVENTRICULAR ZONE

Neuro-oncology (Charlottesville, Va.), 2014-07, Vol.16 (suppl 3), p.iii19-iii19

2014

Volltextzugriff (PDF)

Assessment of image guided accuracy in a skull model : comparison of frameless stereotaxy techniques vs. frame-based localization

Journal of neuro-oncology, 2006, Vol.76 (1), p.65-70

2006

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(127)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Extent of resection influences outcomes for patients with gliomas

Intracranial Aneurysms in Childhood: 27-Year Single-Institution Experience

Miniature in vivo MEMS-based line-scanned dual-axis confocal microscope for point-of-care pathology

Emerging operative strategies in neurosurgical oncology

MECHANISMS OF DISEASE: Neural Stem Cells and the Origin of Gliomas

A Combined Phase 0/1b Trial of ATM Inhibitor AZD1390 in Combination with Radiation in Patients with Newly-Diagnosed, MGMT-Unmethylated Glioblastoma

A Combined Phase 0/2 "Trigger" Trial Evaluating Pamiparib or Olaparib with Concurrent Radiotherapy in Patients with Newly-Diagnosed or Recurrent Glioblastoma

A Combined Phase 0/2 "Trigger" Trial of Niraparib in Combination with Radiation in Patients with Newly-Diagnosed Glioblastoma

505MO A phase 0/Ib study of AZD1390 plus radiotherapy in recurrent glioblastoma patients

341O A phase 0 ‘Trigger’ trial of CDK4/6 plus ERK1/2 inhibitors in recurrent glioblastoma

287MO A phase 0 ‘trigger’ trial of pamiparib in newly diagnosed and recurrent glioblastoma patients

Phase 0 trial of ceritinib in brain metastases and recurrent glioblastoma

427P - Phase 0 trial of ceritinib in brain metastases and recurrent glioblastoma

A phase 0/II clinical trial of a CDK4/6 inhibitor in aggressive meningioma patients

392OA phase 0/II clinical trial of a CDK4/6 inhibitor in aggressive meningioma patients

427PPhase 0 trial of ceritinib in brain metastases and recurrent glioblastoma

392O - A phase 0/II clinical trial of a CDK4/6 inhibitor in aggressive meningioma patients

OS05.8.A A Phase 0/1 ‘Trigger’ Trial of Ribociclib Plus Everolimus in Recurrent High-Grade Glioma

347MO 5-Aminolevulinic acid sonodynamic therapy in recurrent glioblastoma: A first-in-human phase 0/1 clinical trial

OS4.2 Phase 0 trial of Ceritinib in brain metastasis and recurrent glioblastoma

OS8.1 A phase 0/2 clinical trial of a CDK4/6 inhibitor in aggressive meningioma patients

Pediatric intracranial aneurysms: durability of treatment following microsurgical and endovascular management

P01.058 Higher immune associated markers (PD-L1, PD-1, TMB, MSI) in gliosarcoma compared to glioblastoma

GLIOMA STEM CELL HOMING TO THE HUMAN SUBVENTRICULAR ZONE

Assessment of image guided accuracy in a skull model : comparison of frameless stereotaxy techniques vs. frame-based localization

Aktive Filter

Suchergebnisse filtern